Video On Demand

Safety Pharmacology GLP Validation Data Review

10-minute video presentation on demand

Get A Preview Of Sinclair Research's Safety Pharmacology Validation Data 

In this 10-minute video presentation on demand, Dr. Michael R. Gralinski, CEO of CorDynamics, reviews the results of 3 safety pharmacology validation studies that were conducted in 2020 in Sinclair Research's purpose-built telemetry facility to validate GLP Safety Pharmacology service offerings.

Three pharmacological validation studies were conducted in telemetered dogs using well characterized hemodynamic, electrocardiographic, and respiratory positive controls. All three studies demonstrated ability to detect expected effects of positive controls with a high degree of fidelity.

Three pharmacological validation studies were conducted: 

About the Presenter: Dr. Michael R. Gralinski is Chief Executive Officer and Co-founder of CorDynamics, a cardiovascular contract research organization based in Chicago. Dr. Gralinski has extensive experience in pharmaceutical development, including product safety, toxicology and safety pharmacology. He is a Past-President of the Safety Pharmacology Society and holds a B.S. in Pharmacology and Toxicology from the University of Wisconsin-Madison and a Ph.D. in Pharmacology (Cardiovascular) from the University of Michigan. 

Watch The Video Presentation on demand